Concepedia

Xavier Aldeguer Manté

XA

Statistics

Publications

3

Citations

233

H-Index

3

Active since

2020

Affiliations

Imelda Hospital(Current)

Roche (United Kingdom)

Xavier Aldeguer Manté is an author at Imelda Hospital specializing in pharmacotherapy, gastrointestinal inflammation, and pharmacy.

Publications per year

2020–2021

3

Publications

3

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study

Josep Garre‐Olmo, Oriol Turró‐Garriga, Ruth Martí‐Lluch et al. · Comprehensive Psychiatry · 2020 · 47 citations · Full text

Public Health, Population Health Sciences, Psychiatry +11

1–3 of 3